When to Start Anti-HIV Drugs in Patients With Opportunistic Infections
Public ClinicalTrials.gov record NCT00055120. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IV Study of Antiretroviral Therapy for HIV Infected Adults Presenting With Acute Opportunistic Infections: Immediate Versus Deferred Initiation of Antiretroviral Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the effect of starting anti-HIV drugs in HIV infected patients who are being treated for opportunistic infections (OIs). This study will follow two patient groups: those who received anti-HIV drugs soon after being diagnosed with an OI and patients with OIs who deferred beginning anti-HIV drugs until after recovering from the OI.
Study identification
- NCT ID
- NCT00055120
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 283 participants
Conditions and interventions
Interventions
Drug
Eligibility (public fields only)
- Age range
- 13 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2003 (Type not available)
- Primary completion
- Sep 2006 (Actual)
- Completion
- Aug 2007 (Actual)
- Last update posted
- Oct 15, 2014
2003 – 2007
United States locations
- U.S. sites
- 43
- U.S. states
- 18
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, Davis Medical Center | Sacramento | California | 95814 | — |
| University of California, San Diego Antiviral Rese | San Diego | California | 92103 | — |
| San Francisco General Hospital | San Francisco | California | 94110 | — |
| San Mateo County AIDS Program | Stanford | California | 94305-5107 | — |
| Santa Clara Valley Medical Center | Stanford | California | 94305-5107 | — |
| Stanford Univ | Stanford | California | 94305-5107 | — |
| Willow Clinic | Stanford | California | 94305-5107 | — |
| Harbor General/UCLA | Torrance | California | 90502-2052 | — |
| University of Colorado Health Sciences Center, Denver | Denver | Colorado | 80262-3706 | — |
| Univ of Miami | Miami | Florida | 33136-1013 | — |
| Emory University | Atlanta | Georgia | 30308 | — |
| Northwestern University | Chicago | Illinois | 60611-3015 | — |
| Cook County Hospital Core Center | Chicago | Illinois | 60612 | — |
| Methodist Hospital of Indiana | Indianapolis | Indiana | 46202-1261 | — |
| Indiana University Hosp | Indianapolis | Indiana | 46202-5250 | — |
| Wishard Hospital | Indianapolis | Indiana | 46202 | — |
| University of Maryland, Institute of Human Virology | Baltimore | Maryland | 21201 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287-8106 | — |
| Harvard (Massachusetts General Hospital) | Boston | Massachusetts | 02114 | — |
| Beth Israel Deaconess - West Campus | Boston | Massachusetts | 02215 | — |
| Brigham and Womens Hospital | Boston | Massachusetts | 02215 | — |
| Hennepin County Medical Clinic | Minneapolis | Minnesota | 55455-0392 | — |
| St. Louis Connect Care | St Louis | Missouri | 63108-2138 | — |
| Washington University (St. Louis) | St Louis | Missouri | 63108-2138 | — |
| Beth Israel Medical Center | New York | New York | 10003 | — |
| NYU/Bellevue | New York | New York | 10016-6481 | — |
| Columbia University | New York | New York | 10021 | — |
| Community Health Network, Inc. | Rochester | New York | 14642-0001 | — |
| University of Rochester Medical Center | Rochester | New York | 14642-0001 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27514 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267-0405 | — |
| Case Western Reserve University | Cleveland | Ohio | 44106-5083 | — |
| MetroHealth Medical Center | Cleveland | Ohio | 44109-1998 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Presbyterian Medical Center - University of PA | Philadelphia | Pennsylvania | 19104 | — |
| University of Pennsylvania, Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02906 | — |
| The Miriam Hospital | Providence | Rhode Island | 02906 | — |
| Comprehensive Care Clinic | Nashville | Tennessee | 37203 | — |
| University of Texas, Southwestern Medical Center | Dallas | Texas | 75235-9173 | — |
| Univ of Texas, Galveston | Galveston | Texas | 77555-0435 | — |
| University of Washington (Seattle) | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00055120, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 15, 2014 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00055120 live on ClinicalTrials.gov.